Novozymes Overview

  • Status
  • Public
  • Employees
  • 6,115
Employees
  • Stock Symbol
  • NZYM B
Stock Symbol
  • Investments
  • 30
  • Share Price
  • $60.04
  • (As of Thursday Closing)

Novozymes General Information

Description

Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. It's biological solutions create value for its customers by improving yield efficiency and performance while saving energy and generating less waste. The company is headquartered in Denmark.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Stock Exchange
CSE
Primary Office
  • Krogshoejvej 36
  • 2880 Bagsvaerd
  • Denmark
+45 44 00 00 00
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Novozymes Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$60.04 $60.02 $37.92 - $61.58 $16.8B 280M 549K $1.72

Novozymes Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 16,920,889 14,284,722 13,194,520 16,908,172
Revenue 2,157,646 2,155,171 2,277,854 2,202,631
EBITDA 790,199 743,979 783,556 748,206
Net Income 447,227 472,896 510,657 472,783
Total Assets 3,124,048 3,063,954 3,017,384 2,960,808
Total Debt 875,258 508,385 225,802 366,455
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Novozymes Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novozymes‘s full profile, request access.

Request a free trial

Novozymes Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, pri
Biotechnology
Bagsvaerd, Denmark
6,115 As of 2020
00000000

000000

tion ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit
0000000000000
Emeryville, CA
000 As of 0000
00.000
000000000 00.000

0000000

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore
0000000000000
Redwood City, CA
000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Novozymes Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Amyris Formerly VC-backed Emeryville, CA 000 00.000 000000000 00.000
0000000 Formerly VC-backed Redwood City, CA 000 00000 000000 - 000 00000
000 0000 000 00000 Corporate Backed or Acquired York, United Kingdom 000 0000 000000000000 0000
0000000 Private Debt Financed Nicholasville, KY 0000 00000 000000000 00000
00000000 Venture Capital-Backed Berkeley, CA 00 0000 00000000000 0000
You’re viewing 5 of 10 competitors. Get the full list »

Novozymes Executive Team (45)

Name Title Board Seat Contact Info
Ester Baiget Chief Executive Officer & President
Ten Melnik President, Novozymes Biologicals
Lars Green Chief Financial Officer & Executive Vice President
Thomas Videbæk Ph.D Executive Vice President for Research, Innovation and Supplyand Chief Operating Officer
Naja Wivel Investor Relations Coordinator
You’re viewing 5 of 45 executive team members. Get the full list »

Novozymes Board Members (12)

Name Representing Role Since
000000 0000000 Novozymes Board Member, Employee Representative and Senior Operator 000 0000
0000 0000 Novozymes Vice Chairman of the Board and Member of the Audit Committee and the Nomination and Remuneration Committee 000 0000
00000 000000000 Novozymes Board Member & Chairman of the Audit Committee 000 0000
0ø0000 000000000 Novozymes Chairman 000 0000
00000 00000 Self Board Member & Member of the Nomination and Remuneration Committee 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Novozymes Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novozymes Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Novozymes‘s full profile, request access.

Request a free trial

Novozymes Investments & Acquisitions (30)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000000000 0 26-Jun-2020 000000000000000000 000.00 Drug Discovery
0000000000000 13-Dec-2018 00000 00000 00 00.000 Agricultural Chemicals
00000000 000000 (0 04-Apr-2017 000000000 00000 Buildings and Property
0000000000000 15-Sep-2016 000000000000000000 Biotechnology 000000000 0ø0000000
Pacific Vet Group- USA 05-Oct-2015 Merger/Acquisition Biotechnology 00000 000000 0000000
You’re viewing 5 of 30 investments and acquisitions. Get the full list »

Novozymes Subsidiaries (6)

Company Name Industry Location Founded
Pacific Vet Group- USA Biotechnology Fayetteville, AR 2008
0000000000000 Biotechnology Berlin, Germany 0000
0000000000000000 0 Drug Discovery Cork, Ireland 0000
00000000 Food Products Sombreffe, Belgium 0000
000000 00000000000 Drug Discovery Adelaide, Australia 0000
You’re viewing 5 of 6 subsidiaries. Get the full list »

Novozymes Exits (2)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 0000000000 06-Nov-2012 00000 00000 00 00000 Completed
  • 000000000
Roots Sustainable Agricultural Technologies 01-Jul-2001 Merger/Acquisition Completed
To view Novozymes’s complete exits history, request access »